| __timestamp | Grifols, S.A. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 660772000 | 381287000 |
| Thursday, January 1, 2015 | 736435000 | 452612000 |
| Friday, January 1, 2016 | 775266000 | 316800000 |
| Sunday, January 1, 2017 | 860348000 | 330100000 |
| Monday, January 1, 2018 | 814775000 | 265800000 |
| Tuesday, January 1, 2019 | 942821000 | 336200000 |
| Wednesday, January 1, 2020 | 985616000 | 423900000 |
| Friday, January 1, 2021 | 1061508000 | 467000000 |
| Saturday, January 1, 2022 | 1190423000 | 487000000 |
| Sunday, January 1, 2023 | 1254234000 | 477100000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, United Therapeutics Corporation and Grifols, S.A. have demonstrated contrasting strategies in this area.
From 2014 to 2023, Grifols, S.A. saw a steady increase in SG&A expenses, rising by approximately 90%, reflecting their aggressive expansion and marketing strategies. In contrast, United Therapeutics Corporation maintained a more conservative approach, with their SG&A expenses increasing by about 25% over the same period.
This divergence highlights different corporate strategies: Grifols' focus on growth and market penetration versus United Therapeutics' emphasis on cost efficiency. As investors and analysts evaluate these companies, understanding their SG&A optimization strategies provides valuable insights into their operational priorities and financial health.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and Opthea Limited
Who Optimizes SG&A Costs Better? Grifols, S.A. or Novavax, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs Amphastar Pharmaceuticals, Inc.